Novo Nordisk shares jump after U.S. approves Wegovy pill
The approval of Novo’s Wegovy pill gives the drugmaker a first-mover advantage in the race for a potent oral weight-loss medicine, as it tries to claw back market share from Lilly and compounding ma...